BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15016769)

  • 1. Polycystic ovary syndrome in adolescence--a therapeutic conundrum.
    Homburg R; Lambalk CB
    Hum Reprod; 2004 May; 19(5):1039-42. PubMed ID: 15016769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome update in adolescence.
    Hassan A; Gordon CM
    Curr Opin Pediatr; 2007 Aug; 19(4):389-97. PubMed ID: 17630601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment experience with metformin in polycystic ovary syndrome].
    Petrányi G
    Orv Hetil; 2005 May; 146(21):1151-5. PubMed ID: 15991679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acarbose for polycystic ovary syndrome.
    Kircher C; Smith KP
    Ann Pharmacother; 2008 Jun; 42(6):847-51. PubMed ID: 18460589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
    Leeman L; Acharya U
    J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin treatment is effective in obese teenage girls with PCOS.
    De Leo V; Musacchio MC; Morgante G; Piomboni P; Petraglia F
    Hum Reprod; 2006 Sep; 21(9):2252-6. PubMed ID: 16785260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of metformin as first line treatment in polycystic ovary syndrome.
    Abbas M; Gannon M
    Ir Med J; 2008 Feb; 101(2):51-3. PubMed ID: 18450250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.